A detailed history of Abacus Planning Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 40,067 shares of EW stock, worth $2.62 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
40,067
Previous 39,438 1.59%
Holding current value
$2.62 Million
Previous $3.64 Million 27.4%
% of portfolio
0.49%
Previous 0.72%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$59.7 - $93.78 $37,551 - $58,987
629 Added 1.59%
40,067 $2.64 Million
Q2 2024

Jul 30, 2024

BUY
$84.3 - $94.31 $1,601 - $1,791
19 Added 0.05%
39,438 $3.64 Million
Q4 2023

Jan 19, 2024

SELL
$61.71 - $77.76 $4,813 - $6,065
-78 Reduced 0.2%
39,419 $3.01 Million
Q3 2023

Oct 11, 2023

BUY
$69.28 - $93.38 $5,403 - $7,283
78 Added 0.2%
39,497 $2.74 Million
Q2 2023

Jul 06, 2023

SELL
$81.41 - $94.33 $34,599 - $40,090
-425 Reduced 1.07%
39,419 $3.72 Million
Q1 2023

Apr 17, 2023

BUY
$74.26 - $84.51 $27,847 - $31,691
375 Added 0.95%
39,844 $3.3 Million
Q4 2022

Jan 19, 2023

SELL
$68.3 - $87.44 $41,184 - $52,726
-603 Reduced 1.5%
39,469 $0
Q3 2021

Oct 19, 2021

SELL
$102.91 - $122.75 $15,951 - $19,026
-155 Reduced 0.39%
40,072 $4.54 Million
Q2 2021

Jul 20, 2021

SELL
$83.84 - $104.76 $124,921 - $156,092
-1,490 Reduced 3.57%
40,227 $4.17 Million
Q1 2021

Apr 27, 2021

SELL
$78.68 - $90.67 $130,608 - $150,512
-1,660 Reduced 3.83%
41,717 $3.49 Million
Q3 2020

Nov 03, 2020

SELL
$67.19 - $87.44 $38,298 - $49,840
-570 Reduced 1.3%
43,377 $3.46 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $1.68 Million - $2.25 Million
29,276 Added 199.55%
43,947 $3.04 Million
Q1 2020

Apr 30, 2020

SELL
$52.41 - $81.0 $8,542 - $13,203
-163 Reduced 1.1%
14,671 $2.77 Million
Q4 2019

Jan 30, 2020

SELL
$71.7 - $82.09 $5,879 - $6,731
-82 Reduced 0.55%
14,834 $3.46 Million
Q3 2019

Nov 01, 2019

BUY
$61.55 - $75.43 $26,651 - $32,661
433 Added 2.99%
14,916 $3.28 Million
Q2 2019

Aug 12, 2019

SELL
$55.74 - $64.41 $848,920 - $980,964
-15,230 Closed
0 $0
Q1 2019

Apr 25, 2019

SELL
$47.89 - $64.05 $11,110 - $14,859
-232 Reduced 1.5%
15,230 $2.91 Million
Q4 2018

Feb 15, 2019

BUY
$46.41 - $56.94 $272,751 - $334,636
5,877 Added 61.31%
15,462 $2.37 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $444,839 - $545,769
9,585 New
9,585 $836,000
Q4 2018

Jan 25, 2019

SELL
$46.41 - $56.94 $6,033 - $7,402
-130 Reduced 0.83%
15,462 $2.37 Million
Q2 2018

Jul 27, 2018

SELL
$42.45 - $51.3 $24,833 - $30,010
-585 Reduced 3.62%
15,592 $2.27 Million
Q1 2018

May 04, 2018

SELL
$37.19 - $47.45 $2,491 - $3,179
-67 Reduced 0.41%
16,177 $2.26 Million
Q4 2017

Mar 06, 2018

BUY
$33.79 - $39.39 $548,884 - $639,851
16,244
16,244 $1.83 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Abacus Planning Group, Inc. Portfolio

Follow Abacus Planning Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.